| Stem definition | Drug id | CAS RN |
|---|---|---|
| aldose reductase inhibitors | 1021 | 82159-09-9 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
None
| Property | Value | Reference |
|---|---|---|
| MRTD (Maximum Recommended Therapeutic Daily Dose) | 6.71 ยตM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Jan. 1, 1992 | YEAR INTRODUCED |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| MeSH PA | D004791 | Enzyme Inhibitors |
| CHEBI has role | CHEBI:48550 | aldose reductase inhibitors |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Diabetic neuropathy | indication | 230572002 | DOID:9743 |
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 3.02 | acidic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Aldose reductase | Enzyme | INHIBITOR | IC50 | 7.68 | WOMBAT-PK | SCIENTIFIC LITERATURE | |||
| Alcohol dehydrogenase [NADP(+)] | Enzyme | IC50 | 5.59 | CHEMBL | |||||
| Aldo-keto reductase family 1 member B10 | Enzyme | IC50 | 6.48 | CHEMBL | |||||
| Sorbitol dehydrogenase | Enzyme | IC50 | 4.17 | CHEMBL | |||||
| Cytochrome P450 4A11 | Enzyme | INHIBITOR | IC50 | 5.74 | IUPHAR | ||||
| Alcohol dehydrogenase [NADP(+)] | Enzyme | IC50 | 5.82 | CHEMBL | |||||
| Aldose reductase | Enzyme | IC50 | 8 | CHEMBL | |||||
| Aldose reductase | Enzyme | IC50 | 6.77 | CHEMBL | |||||
| Alcohol dehydrogenase [NADP(+)] | Enzyme | IC50 | 5.82 | CHEMBL |
| ID | Source |
|---|---|
| D01688 | KEGG_DRUG |
| C0095278 | UMLSCUI |
| CHEBI:31539 | CHEBI |
| EPR | PDB_CHEM_ID |
| CHEMBL56337 | ChEMBL_ID |
| DB15293 | DRUGBANK_ID |
| C038131 | MESH_SUPPLEMENTAL_RECORD_UI |
| 1549120 | PUBCHEM_CID |
| 11371 | IUPHAR_LIGAND_ID |
| 5896 | INN_ID |
| 424DV0807X | UNII |
None